KNSA Kiniksa Pharmaceuticals RESULTS: Q2, Q2 operating expenses $216.406M, Q2 Net Income $25.432M, Q2 pretax profit $31.145M, Kiniksa Pharma
KNSA Kiniksa Pharmaceuticals RESULTS: Q2, Q2 operating expenses $216.406M, Q2 Net Income $25.432M, Q2 pretax profit $31.145M, Kiniksa Pharmaceuticals Earnings Notes:, - Kiniksa Pharmaceuticals Q2 product REV $243.6M
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.